A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer - Related Studies

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

This study has been completed.

Study NCT00034827. Last updated on May 3, 2007. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Neoplasms
		Breast Neoplasms
		Carcinoma, Non-Small-Cell Lung
		Pancreatic Neoplasms

2	Additional conditions recognized in this trial
		Carcinoma
		Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Lung Diseases
		Lung Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Pancreatic Diseases
		Rectal Diseases
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Skin Diseases
		Thoracic Neoplasms

4	Interventions listed in this trial
		CI-1040

5	Sponsors listed in this trial
		Pfizer